How may this impact your patient’s care?

​

The proposed requirement for California patient’s to obtain B12 medication from an outsourcing facility instead of a compounding pharmacy means that you will no longer be able to have your patient’s medication shipped directly to their home or address of choice. You may not be able to select the pharmacy of choice for your patients, as this rule would prohibit Lee Silsby from serving your California patients. Patients would be required to visit your office to receive their medication.  A change to your patient’s therapy may also occur if outsourcing facilities do not manufacture your patient’s specific drug strength(s) and drug combinations.

​

 

Does Lee Silsby meet California sterile medication quality standards?

​

Yes! Lee Silsby goes above and beyond to meet all the quality requirements in California law. In fact - Lee Silsby is proud to lead the way in industry best practices and quality testing. We understand the importance of the California Board of Pharmacy’s role in protecting the public from harm. However, we respectfully take a stand that this current thinking is inappropriate and creates the very public harm they are tasked to protect.

How can you help?

​

Lee Silsby is leading patient advocacy efforts with the California Board of Pharmacy and the Compounding Committee. Lee Silsby would be honored to speak on behalf of your concerns. You may complete a survey by clicking here to provide essential information on the importance of your patient's access to B12 medication from a compounding pharmacy. You may select to maintain your privacy while providing testimony on this important matter.